ISOTRETINOIN

ISOTRETINOIN was reported 50010 times

ISOTRETINOIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACNE FULMINANS 126 0.6429
1 NO ADVERSE EFFECT 987 0.5459
2 INFLAMMATORY BOWEL DISEASE 5253 0.5363
3 GASTROINTESTINAL INJURY 1261 0.4684
4 PREGNANCY TEST FALSE POSITIVE 192 0.4120
5 EXPOSURE VIA SEMEN 14 0.3256
6 PROCTITIS ULCERATIVE 192 0.3184
7 EPIPHYSES PREMATURE FUSION 92 0.3036
8 NASAL VESTIBULITIS 30 0.3000
9 SELECTIVE ABORTION 52 0.2971
10 NO ADVERSE REACTION 42 0.2877
11 XEROSIS 354 0.2859
12 PREGNANCY TEST NEGATIVE 28 0.2667
13 NO ADVERSE DRUG EFFECT 157 0.2312
14 PROCTOCOLITIS 21 0.2059
15 ACNE CONGLOBATA 16 0.1951
16 ILEITIS 75 0.1948
17 UNINTENDED PREGNANCY 1938 0.1853
18 LIP DRY 1599 0.1759
19 ANOTIA 15 0.1744
20 SAPHO SYNDROME 43 0.1741
21 CROHN'S DISEASE 1141 0.1663
22 ABORTION INDUCED 1441 0.1529
23 ILEAL FISTULA 13 0.1413
24 TRANSMISSION OF DRUG VIA SEMEN 67 0.1390
25 PURGING 14 0.1346
26 DRUG EXPOSURE BEFORE PREGNANCY 133 0.1312
27 RECTAL POLYP 129 0.1307
28 PREGNANCY TEST POSITIVE 49 0.1247
29 PERIRECTAL ABSCESS 137 0.1235
30 CHAPPED LIPS 508 0.1169
31 ANAL POLYP 12 0.1165
32 PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION 14 0.1120
33 ALOPECIA SCARRING 19 0.1038
34 PREGNANCY 2081 0.1038
35 SACROILIITIS 188 0.0995
36 POUCHITIS 82 0.0952
37 IRRITABLE BOWEL SYNDROME 2015 0.0939
38 CHEILITIS 498 0.0919
39 ENTEROCOLONIC FISTULA 12 0.0902
40 COLITIS ULCERATIVE 3809 0.0851
41 CEREBELLAR HYPOPLASIA 14 0.0833
42 BLOOD TRIGLYCERIDES INCREASED 1467 0.0829
43 RECTAL FISSURE 52 0.0825
44 MONONUCLEOSIS SYNDROME 21 0.0817
45 COLONIC POLYP 129 0.0780
46 NEUROBLASTOMA RECURRENT 15 0.0739
47 NIGHT BLINDNESS 116 0.0724
48 PSEUDOPOLYP 26 0.0722
49 PROCTITIS 198 0.0706
50 ANAL STENOSIS 37 0.0694
51 ANAL FISSURE 366 0.0682
52 NEUROBLASTOMA 26 0.0679
53 PREGNANCY OF PARTNER 48 0.0677
54 MULTI-ORGAN DISORDER 132 0.0670
55 EAR MALFORMATION 31 0.0670
56 PYOGENIC GRANULOMA 31 0.0665
57 PRODUCT ADMINISTRATION INTERRUPTED 513 0.0653
58 MEIBOMIAN GLAND DYSFUNCTION 29 0.0640
59 DERMOID CYST 21 0.0631
60 ANAL FISTULA 320 0.0599
61 COLON INJURY 34 0.0591
62 NEUTROPHILIC DERMATOSIS 23 0.0582
63 KERATOCONJUNCTIVITIS SICCA 21 0.0571
64 PATERNAL DRUGS AFFECTING FOETUS 21 0.0560
65 DEVICE RELATED BACTERAEMIA 17 0.0548
66 BENIGN INTRACRANIAL HYPERTENSION 67 0.0533
67 LARGE INTESTINE POLYP 359 0.0518
68 DANDY-WALKER SYNDROME 13 0.0502
69 ARTHRITIS ENTEROPATHIC 16 0.0491
70 INTERNAL INJURY 32 0.0491
71 MOOD ALTERED 1322 0.0484
72 EXPOSURE VIA BODY FLUID 38 0.0483
73 ECZEMA ASTEATOTIC 22 0.0467
74 ANOMALY OF EXTERNAL EAR CONGENITAL 14 0.0443
75 NORMAL NEWBORN 237 0.0436
76 TERATOGENICITY 13 0.0430
77 PILONIDAL CYST 21 0.0429
78 INFECTIOUS MONONUCLEOSIS 93 0.0414
79 KELOID SCAR 21 0.0407
80 COLONIC FISTULA 23 0.0404
81 PRODUCT DISPENSING ISSUE 172 0.0402
82 LIP HAEMORRHAGE 51 0.0400
83 PREGNANCY ON ORAL CONTRACEPTIVE 103 0.0393
84 NASAL DRYNESS 238 0.0379
85 CHOLANGITIS SCLEROSING 78 0.0379
86 COLONIC STENOSIS 13 0.0378
87 EDUCATIONAL PROBLEM 62 0.0373
88 KERATOCONUS 14 0.0372
89 DRUG EXPOSURE DURING PREGNANCY 1214 0.0357
90 POST INFLAMMATORY PIGMENTATION CHANGE 16 0.0353
91 ORGASMIC SENSATION DECREASED 13 0.0344
92 PREGNANCY ON CONTRACEPTIVE 50 0.0342
93 CHRONIC FATIGUE SYNDROME 45 0.0323
94 LIPIDS INCREASED 63 0.0312
95 ECTOPIC PREGNANCY 94 0.0305
96 DEPRESSIVE SYMPTOM 107 0.0303
97 SELF-INJURIOUS IDEATION 121 0.0288
98 LIVE BIRTH 239 0.0285
99 EXPOSURE DURING PREGNANCY 1774 0.0285
100 LIP EXFOLIATION 37 0.0278
101 BLOOD TRIGLYCERIDES ABNORMAL 24 0.0274
102 RECTAL ABSCESS 45 0.0268
103 URETHRITIS 14 0.0258
104 DEPRESSION 5849 0.0257
105 ANAL ABSCESS 137 0.0254
106 ACNE CYSTIC 76 0.0252
107 ABORTION 73 0.0250
108 GENITAL HYPOAESTHESIA 25 0.0245
109 CONGENITAL NOSE MALFORMATION 13 0.0244
110 MICROGNATHIA 12 0.0240
111 SMALL INTESTINAL OBSTRUCTION 295 0.0239
112 SUICIDAL IDEATION 2160 0.0236
113 INTESTINAL OBSTRUCTION 880 0.0233
114 GASTROINTESTINAL OEDEMA 41 0.0232
115 APHTHOUS STOMATITIS 52 0.0225
116 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 15 0.0221
117 ACNE PUSTULAR 18 0.0220
118 PELVIC ABSCESS 25 0.0218
119 ANGULAR CHEILITIS 15 0.0217
120 HAEMORRHOIDS 421 0.0216
121 ENTEROCUTANEOUS FISTULA 19 0.0215
122 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 23 0.0213
123 ILEAL PERFORATION 14 0.0211
124 TREATMENT NONCOMPLIANCE 1142 0.0209
125 ILEAL STENOSIS 36 0.0202
126 PYODERMA GANGRENOSUM 72 0.0200
127 COLITIS 738 0.0194
128 RECTAL HAEMORRHAGE 836 0.0194
129 CALCULUS URETERIC 14 0.0193
130 MOOD SWINGS 616 0.0193
131 EPISCLERITIS 13 0.0188
132 DRY SKIN 2463 0.0184
133 MUCOSAL DRYNESS 37 0.0184
134 CLEFT LIP 16 0.0183
135 INGROWING NAIL 43 0.0182
136 ADVERSE DRUG REACTION 1631 0.0181
137 LICHEN SCLEROSUS 12 0.0175
138 IMPETIGO 26 0.0174
139 ABORTION SPONTANEOUS 699 0.0174
140 EXCESSIVE GRANULATION TISSUE 14 0.0174
141 ABORTION MISSED 22 0.0173
142 ENTEROVESICAL FISTULA 13 0.0171
143 BLOOD CHOLESTEROL INCREASED 788 0.0169
144 HIDRADENITIS 152 0.0167
145 LIPIDS ABNORMAL 12 0.0166
146 PUSTULE 39 0.0164
147 PATERNAL EXPOSURE DURING PREGNANCY 14 0.0162
148 BIPOLAR DISORDER 173 0.0159
149 AFFECTIVE DISORDER 124 0.0158
150 ERYTHEMA NODOSUM 54 0.0154
151 INFERTILITY 23 0.0153
152 WISDOM TEETH REMOVAL 20 0.0152
153 EOSINOPHILIC PNEUMONIA ACUTE 13 0.0150
154 HIGH DENSITY LIPOPROTEIN DECREASED 50 0.0150
155 GENERALISED ANXIETY DISORDER 22 0.0149
156 GROWTH RETARDATION 44 0.0149
157 HYPERTRIGLYCERIDAEMIA 87 0.0148
158 PARONYCHIA 64 0.0145
159 FEELINGS OF WORTHLESSNESS 19 0.0145
160 SEBORRHOEIC DERMATITIS 24 0.0145
161 CLEFT PALATE 28 0.0145
162 DRY EYE 718 0.0144
163 INTESTINAL FISTULA 20 0.0142
164 THERAPY CESSATION 729 0.0142
165 MATERNAL EXPOSURE BEFORE PREGNANCY 97 0.0142
166 IRON DEFICIENCY ANAEMIA 128 0.0139
167 SOCIAL AVOIDANT BEHAVIOUR 80 0.0138
168 MAJOR DEPRESSION 100 0.0137
169 FEMALE GENITAL TRACT FISTULA 23 0.0135
170 EPISTAXIS 996 0.0133
171 SKIN PAPILLOMA 53 0.0132
172 ADJUSTMENT DISORDER 17 0.0131
173 HIGH DENSITY LIPOPROTEIN INCREASED 13 0.0131
174 SUNBURN 94 0.0126
175 ACNE 954 0.0126
176 INTUSSUSCEPTION 12 0.0126
177 BONE MARROW OEDEMA 13 0.0125
178 SELF INJURIOUS BEHAVIOUR 38 0.0124
179 POLYP 81 0.0124
180 POLYCYSTIC OVARIES 19 0.0122
181 ABSCESS INTESTINAL 26 0.0121
182 MORBID THOUGHTS 14 0.0119
183 ILEAL ULCER 12 0.0119
184 VIOLENCE-RELATED SYMPTOM 18 0.0116
185 GRANULOMATOSIS WITH POLYANGIITIS 14 0.0116
186 IDIOPATHIC INTRACRANIAL HYPERTENSION 26 0.0116
187 INJURY 812 0.0115
188 EXPOSURE VIA FATHER 15 0.0115
189 MELANOCYTIC NAEVUS 50 0.0114
190 GUN SHOT WOUND 21 0.0111
191 MYOPIA 26 0.0109
192 MEGACOLON 17 0.0108
193 SCAR 185 0.0108
194 PHOTOSENSITIVITY REACTION 178 0.0108
195 TONSILLECTOMY 18 0.0108
196 SKIN INDURATION 22 0.0106
197 PEPTIC ULCER 35 0.0105
198 HIRSUTISM 14 0.0105
199 VULVOVAGINAL DRYNESS 34 0.0105
200 BIPOLAR I DISORDER 23 0.0105
201 PRODUCT DISPENSING ERROR 227 0.0104
202 PAPULE 73 0.0104
203 DECREASED INTEREST 61 0.0103
204 MENTAL DISORDER 446 0.0102
205 INCISIONAL HERNIA 14 0.0101
206 LOW DENSITY LIPOPROTEIN INCREASED 78 0.0101
207 CYSTITIS INTERSTITIAL 16 0.0099
208 SKIN FRAGILITY 24 0.0099
209 LOSS OF LIBIDO 88 0.0098
210 DERMAL CYST 24 0.0098
211 BLOOD UREA DECREASED 12 0.0097
212 FISTULA 108 0.0096
213 ABDOMINAL ABSCESS 42 0.0095
214 ERECTILE DYSFUNCTION 243 0.0095
215 SUICIDAL BEHAVIOUR 39 0.0094
216 AFFECT LABILITY 90 0.0093
217 DYSMORPHISM 22 0.0093
218 HORDEOLUM 40 0.0092
219 LARGE INTESTINAL ULCER 25 0.0092
220 DEPRESSED MOOD 484 0.0091
221 DUODENITIS 28 0.0091
222 OSTEOPENIA 138 0.0091
223 ANGER 307 0.0091
224 CALCINOSIS 20 0.0089
225 PERSONALITY CHANGE 83 0.0089
226 SUICIDE ATTEMPT 537 0.0088
227 TEARFULNESS 38 0.0088
228 DRUG DISPENSING ERROR 135 0.0088
229 SKIN STRIAE 13 0.0087
230 BLEPHARITIS 35 0.0087
231 NEGATIVE THOUGHTS 25 0.0085
232 LABORATORY TEST ABNORMAL 246 0.0083
233 PANIC ATTACK 303 0.0083
234 CONGENITAL ANOMALY 64 0.0083
235 CERVICAL DYSPLASIA 18 0.0082
236 LIGAMENT RUPTURE 36 0.0081
237 DEPRESSION SUICIDAL 28 0.0081
238 KNEE DEFORMITY 12 0.0081
239 LIP BLISTER 22 0.0081
240 COSTOCHONDRITIS 13 0.0080
241 INTESTINAL POLYP 13 0.0079
242 MATERNAL EXPOSURE DURING PREGNANCY 697 0.0078
243 PAPILLOEDEMA 35 0.0077
244 ROSACEA 36 0.0077
245 OBSESSIVE-COMPULSIVE DISORDER 62 0.0077
246 INTRACRANIAL PRESSURE INCREASED 43 0.0077
247 TREATMENT DELAYED 13 0.0075
248 CYST 93 0.0075
249 LARGE INTESTINE PERFORATION 52 0.0075
250 STRABISMUS 22 0.0075
251 FACIAL PALSY 16 0.0074
252 CLOSTRIDIAL INFECTION 25 0.0074
253 PREGNANCY WITH CONTRACEPTIVE DEVICE 66 0.0074
254 DERMATITIS 154 0.0073
255 DRUG PRESCRIBING ERROR 141 0.0073
256 DIVERTICULUM 52 0.0073
257 LIP PAIN 21 0.0073
258 HENOCH-SCHONLEIN PURPURA 16 0.0073
259 TYPE 1 DIABETES MELLITUS 44 0.0073
260 SEBORRHOEA 26 0.0071
261 PSYCHIATRIC SYMPTOM 52 0.0070
262 SOCIAL PROBLEM 29 0.0070
263 HEPATIC ENZYME INCREASED 476 0.0070
264 COLITIS MICROSCOPIC 33 0.0070
265 LIVER FUNCTION TEST ABNORMAL 202 0.0069
266 ORAL HERPES 135 0.0069
267 ANXIETY DISORDER 23 0.0069
268 ANXIETY 1941 0.0068
269 MICROCYTIC ANAEMIA 14 0.0067
270 MEAN CELL HAEMOGLOBIN DECREASED 12 0.0066
271 TONSILLITIS 34 0.0065
272 FLAT AFFECT 15 0.0065
273 NECK INJURY 19 0.0065
274 LYMPHOCYTE COUNT INCREASED 21 0.0064
275 HEPATIC ENZYME ABNORMAL 32 0.0064
276 WOUND SECRETION 25 0.0064
277 EYELID IRRITATION 16 0.0064
278 ASPARTATE AMINOTRANSFERASE INCREASED 338 0.0064
279 SELF-MEDICATION 26 0.0063
280 IMPULSE-CONTROL DISORDER 13 0.0063
281 DIVERTICULITIS 175 0.0063
282 LIVER FUNCTION TEST INCREASED 135 0.0063
283 BLOOD CHOLESTEROL ABNORMAL 29 0.0063
284 ENTERITIS 40 0.0062
285 CRYING 226 0.0062
286 ULCERATIVE KERATITIS 17 0.0062
287 LYMPHADENITIS 15 0.0062
288 GLOMERULONEPHRITIS 15 0.0061
289 PRODUCT DOSE OMISSION ISSUE 1794 0.0061
290 SKIN ODOUR ABNORMAL 24 0.0061
291 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 14 0.0060
292 PREMATURE LABOUR 34 0.0060
293 EMOTIONAL DISTRESS 722 0.0060
294 OESOPHAGITIS 65 0.0059
295 GASTROINTESTINAL DISORDER 532 0.0059
296 APPENDICITIS 55 0.0059
297 RHINITIS ALLERGIC 26 0.0058
298 PSEUDOMEMBRANOUS COLITIS 13 0.0058
299 LIPOMA 15 0.0058
300 SELF ESTEEM DECREASED 14 0.0058
301 HYSTERECTOMY 50 0.0058
302 VISUAL DISTURBANCE 33 0.0057
303 OTITIS MEDIA 19 0.0057
304 ADVERSE EVENT 526 0.0057
305 APATHY 83 0.0057
306 ALANINE AMINOTRANSFERASE ABNORMAL 12 0.0057
307 PANIC DISORDER 22 0.0057
308 EMOTIONAL DISORDER 174 0.0056
309 PRODUCT PRESCRIBING ERROR 134 0.0056
310 AGGRESSION 281 0.0056
311 LICHEN PLANUS 13 0.0056
312 PROCTALGIA 36 0.0056
313 INTENTIONAL SELF-INJURY 112 0.0055
314 SKIN WRINKLING 15 0.0055
315 MATERNAL DRUGS AFFECTING FOETUS 42 0.0055
316 INTESTINAL STENOSIS 23 0.0054
317 ALANINE AMINOTRANSFERASE INCREASED 334 0.0054
318 SUBCUTANEOUS ABSCESS 26 0.0054
319 HEART DISEASE CONGENITAL 19 0.0054
320 HAEMATOCHEZIA 296 0.0054
321 IRRITABILITY 322 0.0053
322 IMPULSIVE BEHAVIOUR 20 0.0053
323 APPENDICECTOMY 19 0.0053
324 PHARYNGOLARYNGEAL PAIN 28 0.0053
325 OESOPHAGEAL ULCER 20 0.0052
326 PHARYNGITIS 64 0.0052
327 ANORGASMIA 14 0.0052
328 ILEUS 64 0.0051
329 OVARIAN CYST 51 0.0051
330 LYME DISEASE 17 0.0051
331 POST-TRAUMATIC STRESS DISORDER 34 0.0051
332 PLEURITIC PAIN 14 0.0051
333 MYALGIA 855 0.0050
334 PRODUCT PRESCRIBING ISSUE 109 0.0050
335 VAGINAL HAEMORRHAGE 216 0.0050
336 KERATITIS 15 0.0049
337 FEELING OF DESPAIR 23 0.0049
338 FACIAL PAIN 44 0.0049
339 HERPES SIMPLEX 32 0.0049
340 PSYCHOTIC DISORDER 144 0.0049
341 FOLLICULITIS 51 0.0049
342 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 164 0.0049
343 ARTHRALGIA 1989 0.0048
344 FREQUENT BOWEL MOVEMENTS 129 0.0048
345 APHTHOUS ULCER 37 0.0048
346 AUTOIMMUNE THYROIDITIS 18 0.0048
347 VENTRICULAR SEPTAL DEFECT 27 0.0047
348 TENDONITIS 73 0.0047
349 HOMICIDAL IDEATION 19 0.0047
350 SPONDYLITIS 17 0.0047
351 INTERVERTEBRAL DISC DEGENERATION 43 0.0046
352 BEHAVIOUR DISORDER 25 0.0046
353 ENDOMETRIOSIS 22 0.0046
354 RASH PUSTULAR 33 0.0045
355 CONJUNCTIVITIS 84 0.0045
356 CHOLECYSTITIS CHRONIC 30 0.0045
357 BREAST SWELLING 12 0.0045
358 OESOPHAGEAL DISORDER 17 0.0044
359 DIARRHOEA HAEMORRHAGIC 41 0.0044
360 ANTINUCLEAR ANTIBODY POSITIVE 14 0.0043
361 HALLUCINATION, AUDITORY 68 0.0043
362 ABNORMAL BEHAVIOUR 169 0.0043
363 GASTRITIS 112 0.0043
364 PLATELET COUNT INCREASED 55 0.0042
365 NODULE 55 0.0042
366 ARTHRITIS 329 0.0042
367 SKIN ATROPHY 24 0.0042
368 THERAPEUTIC PRODUCT INEFFECTIVE 16 0.0041
369 ECZEMA 216 0.0041
370 INFUSION SITE PRURITUS 13 0.0041
371 DIVERTICULUM INTESTINAL 18 0.0041
372 SEXUAL DYSFUNCTION 48 0.0041
373 BACK PAIN 947 0.0041
374 BLOOD ALKALINE PHOSPHATASE INCREASED 101 0.0041
375 TINNITUS 186 0.0040
376 HYDROCEPHALUS 22 0.0040
377 HYPERKERATOSIS 22 0.0040
378 ABDOMINAL PAIN 927 0.0040
379 BLOOD CREATINE PHOSPHOKINASE INCREASED 114 0.0040
380 IRITIS 12 0.0039
381 ADVERSE REACTION 52 0.0039
382 CLAVICLE FRACTURE 15 0.0039
383 SKIN MASS 26 0.0039
384 PARANOIA 67 0.0039
385 HYPERTRANSAMINASAEMIA 27 0.0039
386 MONOCYTE COUNT INCREASED 14 0.0039
387 DISTURBANCE IN ATTENTION 206 0.0038
388 HIATUS HERNIA 49 0.0038
389 DERMATITIS ACNEIFORM 23 0.0038
390 CLOSTRIDIUM DIFFICILE COLITIS 40 0.0038
391 VIITH NERVE PARALYSIS 13 0.0038
392 CONCUSSION 29 0.0037
393 NEPHROLITHIASIS 170 0.0037
394 BLOOD TEST ABNORMAL 52 0.0037
395 SKIN PLAQUE 31 0.0037
396 VISION BLURRED 497 0.0036
397 AUTOIMMUNE DISORDER 35 0.0036
398 GASTROENTERITIS 52 0.0036
399 PARADOXICAL DRUG REACTION 13 0.0035
400 ALCOHOL USE 13 0.0035
401 HYPERLIPIDAEMIA 42 0.0035
402 ABSCESS 56 0.0035
403 STAPHYLOCOCCAL INFECTION 115 0.0035
404 DRUG INTOLERANCE 335 0.0035
405 VITAMIN B12 DEFICIENCY 14 0.0035
406 THERAPY INTERRUPTED 246 0.0034
407 DERMATITIS CONTACT 39 0.0034
408 PHOTOPHOBIA 64 0.0034
409 VEIN DISORDER 17 0.0034
410 SCOLIOSIS 21 0.0034
411 CONJUNCTIVAL HYPERAEMIA 12 0.0034
412 VIRAL UPPER RESPIRATORY TRACT INFECTION 16 0.0034
413 SKIN LESION 91 0.0033
414 VULVOVAGINAL MYCOTIC INFECTION 13 0.0033
415 URINE ABNORMALITY 15 0.0033
416 PATENT DUCTUS ARTERIOSUS 13 0.0033
417 SKIN HYPERPIGMENTATION 28 0.0033
418 CANDIDIASIS 13 0.0032
419 PHARYNGITIS STREPTOCOCCAL 35 0.0032
420 HEADACHE 2013 0.0032
421 COMPLETED SUICIDE 265 0.0032
422 FURUNCLE 25 0.0032
423 ALOPECIA 617 0.0031
424 COLITIS ISCHAEMIC 21 0.0031
425 HYPERCHOLESTEROLAEMIA 30 0.0031
426 DEAFNESS UNILATERAL 17 0.0031
427 THINKING ABNORMAL 57 0.0031
428 ABSCESS LIMB 13 0.0030
429 DYSPAREUNIA 14 0.0030
430 ALCOHOLISM 13 0.0030
431 INTESTINAL PERFORATION 34 0.0030
432 MIGRAINE 289 0.0030
433 TENSION HEADACHE 13 0.0030
434 APPETITE DISORDER 20 0.0030
435 TIBIA FRACTURE 14 0.0030
436 JOINT DISLOCATION 31 0.0029
437 GASTROOESOPHAGEAL REFLUX DISEASE 236 0.0029
438 CAESAREAN SECTION 34 0.0029
439 REBOUND EFFECT 33 0.0029
440 ROAD TRAFFIC ACCIDENT 122 0.0029
441 SKIN DISORDER 97 0.0029
442 VARICOSE VEIN 15 0.0029
443 STREPTOCOCCAL INFECTION 16 0.0029
444 HORMONE LEVEL ABNORMAL 14 0.0029
445 GALLBLADDER DISORDER 51 0.0029
446 POLYARTHRITIS 15 0.0028
447 SCAB 32 0.0028
448 ANOREXIA 36 0.0028
449 DEAFNESS 73 0.0028
450 MENSTRUAL DISORDER 23 0.0028
451 BLOOD ALBUMIN DECREASED 22 0.0028
452 VISUAL FIELD DEFECT 20 0.0028
453 SURGERY 161 0.0027
454 MENSTRUATION IRREGULAR 73 0.0027
455 ANHEDONIA 71 0.0027
456 DUODENAL ULCER 19 0.0027
457 ILEUS PARALYTIC 12 0.0027
458 AMENORRHOEA 47 0.0027
459 EAR PAIN 52 0.0027
460 MYOSITIS 24 0.0027
461 HYPERCALCAEMIA 33 0.0027
462 IMPAIRED WORK ABILITY 57 0.0027
463 INCORRECT DOSAGE ADMINISTERED 13 0.0027
464 UVEITIS 36 0.0027
465 FRACTURE 50 0.0026
466 DYSMENORRHOEA 35 0.0026
467 PRODUCT USE ISSUE 495 0.0026
468 GASTRIC ULCER 50 0.0026
469 INGUINAL HERNIA 16 0.0026
470 EXOSTOSIS 24 0.0026
471 EAR DISORDER 12 0.0026
472 HAIR GROWTH ABNORMAL 18 0.0026
473 GRAND MAL CONVULSION 24 0.0026
474 PIGMENTATION DISORDER 16 0.0026
475 MANIA 42 0.0026
476 MENINGITIS 17 0.0025
477 VITREOUS FLOATERS 25 0.0025
478 THERAPY CHANGE 25 0.0025
479 HYDRONEPHROSIS 19 0.0025
480 BONE DISORDER 46 0.0025
481 VIRAL INFECTION 84 0.0025
482 FOETAL EXPOSURE DURING PREGNANCY 203 0.0025
483 TENDERNESS 26 0.0025
484 PANCREATITIS 131 0.0025
485 PRODUCT USE COMPLAINT 39 0.0025
486 SCHIZOPHRENIA 30 0.0025
487 HAIR TEXTURE ABNORMAL 33 0.0025
488 ENCEPHALITIS 17 0.0025
489 LOWER GASTROINTESTINAL HAEMORRHAGE 18 0.0024
490 CHOLECYSTITIS 29 0.0024
491 SPINAL DISORDER 23 0.0024
492 ANKYLOSING SPONDYLITIS 32 0.0024
493 PRODUCT SIZE ISSUE 13 0.0024
494 STRESS FRACTURE 13 0.0024
495 ANAEMIA 459 0.0024
496 VASCULITIS 28 0.0024
497 LIP SWELLING 80 0.0024
498 HAND FRACTURE 17 0.0024
499 SKIN EXFOLIATION 202 0.0024
500 COLON CANCER 35 0.0023
501 ODYNOPHAGIA 14 0.0023
502 HEARING IMPAIRED 14 0.0023
503 PRODUCT QUALITY ISSUE 317 0.0023
504 DEVELOPMENTAL DELAY 21 0.0023
505 MALNUTRITION 26 0.0023
506 EYE INFLAMMATION 22 0.0023
507 EATING DISORDER 49 0.0023
508 MALABSORPTION 12 0.0023
509 REFUSAL OF TREATMENT BY PATIENT 15 0.0023
510 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 126 0.0023
511 MULTIPLE ALLERGIES 18 0.0023
512 BLOOD BILIRUBIN INCREASED 62 0.0023
513 CONVULSION 131 0.0023
514 LYMPHADENOPATHY 81 0.0023
515 EYE DISORDER 75 0.0023
516 DEEP VEIN THROMBOSIS 148 0.0023
517 ATRIAL SEPTAL DEFECT 19 0.0023
518 DRY THROAT 23 0.0023
519 DELUSION 35 0.0023
520 OSTEOARTHRITIS 94 0.0022
521 PHOTOPSIA 14 0.0022
522 MUSCULOSKELETAL DISORDER 42 0.0022
523 DIPLOPIA 57 0.0022
524 MENTAL IMPAIRMENT 53 0.0022
525 HERNIA 42 0.0022
526 BLINDNESS TRANSIENT 16 0.0022
527 NO ADVERSE EVENT 393 0.0022
528 RED BLOOD CELL SEDIMENTATION RATE INCREASED 24 0.0022
529 QUALITY OF LIFE DECREASED 29 0.0022
530 TRANSAMINASES INCREASED 48 0.0022
531 SKIN FISSURES 42 0.0021
532 EYE INFECTION 24 0.0021
533 WALKING AID USER 14 0.0021
534 DRUG ABUSER 13 0.0021
535 UNEVALUABLE EVENT 159 0.0021
536 UPPER RESPIRATORY TRACT INFECTION 97 0.0021
537 HYPERSOMNIA 60 0.0021
538 SKIN HAEMORRHAGE 31 0.0021
539 VISUAL IMPAIRMENT 258 0.0021
540 RENAL DISORDER 97 0.0021
541 EPSTEIN-BARR VIRUS INFECTION 13 0.0021
542 MUSCLE STRAIN 18 0.0021
543 EYELID OEDEMA 24 0.0021
544 HEPATIC STEATOSIS 38 0.0020
545 ONYCHOCLASIS 14 0.0020
546 BLOOD IRON DECREASED 24 0.0020
547 ACCIDENT 24 0.0020
548 DRY MOUTH 163 0.0020
549 FEAR 54 0.0020
550 OCULAR HYPERAEMIA 95 0.0020
551 LEUKOCYTOSIS 36 0.0020
552 EYE PAIN 112 0.0020
553 LUPUS-LIKE SYNDROME 18 0.0020
554 MUSCLE DISORDER 16 0.0020
555 CARDIAC MURMUR 17 0.0020
556 NERVE COMPRESSION 18 0.0019
557 IMPAIRED QUALITY OF LIFE 28 0.0019
558 OSTEOPOROSIS 80 0.0019
559 GASTROENTERITIS VIRAL 35 0.0019
560 PRODUCT PHYSICAL ISSUE 39 0.0019
561 ACUTE MYELOID LEUKAEMIA 30 0.0019
562 HEAD DISCOMFORT 34 0.0019
563 HEAVY MENSTRUAL BLEEDING 17 0.0019
564 FIBROMYALGIA 45 0.0018
565 BRAIN FOG 29 0.0018
566 BRAIN NEOPLASM 17 0.0018
567 VISUAL ACUITY REDUCED 61 0.0018
568 GROIN PAIN 16 0.0018
569 DEVICE RELATED INFECTION 28 0.0018
570 MOUTH ULCERATION 38 0.0018
571 POOR QUALITY PRODUCT ADMINISTERED 19 0.0018
572 MUSCULOSKELETAL DISCOMFORT 31 0.0018
573 CHOLELITHIASIS 59 0.0018
574 WHITE BLOOD CELL COUNT INCREASED 69 0.0018
575 PROTEINURIA 34 0.0018
576 ILL-DEFINED DISORDER 108 0.0018
577 FUNGAL INFECTION 59 0.0018
578 NECK PAIN 98 0.0018
579 CHOLECYSTECTOMY 20 0.0017
580 EYE SWELLING 65 0.0017
581 SINUSITIS 178 0.0017
582 RHINITIS 14 0.0017
583 IMPAIRED HEALING 57 0.0017
584 COELIAC DISEASE 17 0.0017
585 THERAPY PARTIAL RESPONDER 27 0.0017
586 GASTROINTESTINAL PAIN 19 0.0017
587 AUTOIMMUNE HEPATITIS 12 0.0017
588 LIGAMENT SPRAIN 17 0.0017
589 PULMONARY EMBOLISM 163 0.0017
590 TREATMENT FAILURE 142 0.0017
591 DEFAECATION URGENCY 12 0.0017
592 BONE PAIN 100 0.0017
593 SKIN REACTION 24 0.0017
594 LACERATION 16 0.0017
595 PURPURA 15 0.0017
596 INSOMNIA 450 0.0017
597 THYROID DISORDER 26 0.0017
598 JOINT INJURY 36 0.0017
599 RASH 733 0.0017
600 PAIN OF SKIN 45 0.0017
601 ABDOMINAL DISCOMFORT 280 0.0017
602 GASTROINTESTINAL INFLAMMATION 13 0.0017
603 AGITATION 121 0.0016
604 THROMBOTIC MICROANGIOPATHY 16 0.0016
605 ULCER 26 0.0016
606 HEPATOMEGALY 16 0.0016
607 SLEEP APNOEA SYNDROME 31 0.0016
608 SKIN INFECTION 18 0.0016
609 BREAST TENDERNESS 12 0.0016
610 IMMUNE SYSTEM DISORDER 21 0.0016
611 INFLAMMATION 82 0.0016
612 KIDNEY INFECTION 31 0.0016
613 POOR QUALITY SLEEP 34 0.0016
614 MENORRHAGIA 31 0.0016
615 THIRST 28 0.0016
616 SUPRAVENTRICULAR TACHYCARDIA 15 0.0016
617 HALLUCINATION, VISUAL 33 0.0016
618 CHEST PAIN 288 0.0016
619 BLINDNESS 63 0.0015
620 VITAMIN D DEFICIENCY 15 0.0015
621 GASTRIC DISORDER 52 0.0015
622 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 107 0.0015
623 PYELONEPHRITIS 13 0.0015
624 FLANK PAIN 14 0.0015
625 PRODUCT AVAILABILITY ISSUE 34 0.0015
626 OROPHARYNGEAL PAIN 138 0.0015
627 HEPATITIS 38 0.0015
628 ERYTHEMA 305 0.0015
629 SPINAL OSTEOARTHRITIS 13 0.0015
630 DISEASE RECURRENCE 70 0.0015
631 NEUTROPHIL COUNT INCREASED 15 0.0015
632 BRONCHITIS 108 0.0015
633 CONTRAINDICATED PRODUCT ADMINISTERED 44 0.0015
634 ABDOMINAL PAIN UPPER 299 0.0015
635 SPLENOMEGALY 17 0.0014
636 CONDITION AGGRAVATED 438 0.0014
637 PETECHIAE 15 0.0014
638 OPTIC NEURITIS 13 0.0014
639 BLOOD URINE PRESENT 27 0.0014
640 ARTHROPATHY 79 0.0014
641 CHROMATURIA 32 0.0014
642 NERVOUS SYSTEM DISORDER 44 0.0014
643 HAEMATURIA 48 0.0014
644 GAMMA-GLUTAMYLTRANSFERASE INCREASED 31 0.0014
645 RHABDOMYOLYSIS 58 0.0014
646 JOINT STIFFNESS 36 0.0014
647 NIGHT SWEATS 44 0.0014
648 NERVE INJURY 15 0.0013
649 VENTRICULAR EXTRASYSTOLES 14 0.0013
650 BASAL CELL CARCINOMA 21 0.0013
651 ATELECTASIS 13 0.0013
652 SINUS BRADYCARDIA 13 0.0013
653 ORAL PAIN 30 0.0013
654 EYE IRRITATION 77 0.0013
655 GOUT 24 0.0013
656 MUSCULOSKELETAL PAIN 70 0.0013
657 ILLNESS 137 0.0013
658 PREMATURE BABY 40 0.0013
659 DYSPHAGIA 126 0.0013
660 MYDRIASIS 17 0.0013
661 KNEE OPERATION 13 0.0013
662 OBESITY 21 0.0013
663 SWELLING FACE 85 0.0013
664 HYPOTONIA 13 0.0013
665 NIGHTMARE 45 0.0013
666 HALLUCINATION 98 0.0013
667 PHARYNGEAL OEDEMA 20 0.0013
668 WEIGHT DECREASED 362 0.0013
669 METRORRHAGIA 22 0.0013
670 MASS 18 0.0013
671 VAGINAL DISCHARGE 13 0.0013
672 IMMUNODEFICIENCY 19 0.0013
673 DERMATITIS ALLERGIC 16 0.0013
674 SINUS CONGESTION 17 0.0013
675 HEPATIC CYTOLYSIS 16 0.0013
676 RASH PAPULAR 28 0.0012
677 SKIN DISCOLOURATION 57 0.0012
678 LIVER DISORDER 55 0.0012
679 LETHARGY 71 0.0012
680 MUSCULOSKELETAL CHEST PAIN 19 0.0012
681 URTICARIA 205 0.0012
682 DYSPEPSIA 120 0.0012
683 DRUG EFFECT LESS THAN EXPECTED 18 0.0012
684 HAEMATOCRIT DECREASED 24 0.0012
685 SINUS TACHYCARDIA 17 0.0012
686 BRAIN INJURY 12 0.0012
687 SLEEP DISORDER 84 0.0012
688 INTERVERTEBRAL DISC PROTRUSION 26 0.0012
689 SKIN IRRITATION 54 0.0012
690 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 211 0.0012
691 AMNESIA 76 0.0012
692 DYSURIA 43 0.0012
693 EAR INFECTION 31 0.0012
694 OCULAR DISCOMFORT 13 0.0012
695 LOCALISED INFECTION 28 0.0012
696 BURSITIS 14 0.0012
697 FEELING ABNORMAL 275 0.0011
698 LOWER LIMB FRACTURE 22 0.0011
699 BLOOD LACTATE DEHYDROGENASE INCREASED 18 0.0011
700 TENDON RUPTURE 14 0.0011
701 CHOKING 22 0.0011
702 HYPOTHYROIDISM 36 0.0011
703 SYSTEMIC LUPUS ERYTHEMATOSUS 40 0.0011
704 FATIGUE 877 0.0011
705 NAUSEA 890 0.0011
706 MADAROSIS 13 0.0011
707 FOOT FRACTURE 21 0.0011
708 HAEMATEMESIS 28 0.0011
709 BACK INJURY 12 0.0011
710 GINGIVAL BLEEDING 15 0.0011
711 ANKLE FRACTURE 17 0.0011
712 PALPITATIONS 128 0.0011
713 GLAUCOMA 21 0.0011
714 HYPERSENSITIVITY 202 0.0011
715 DEHYDRATION 145 0.0011
716 WRIST FRACTURE 13 0.0011
717 PERICARDIAL EFFUSION 25 0.0011
718 BODY TEMPERATURE INCREASED 22 0.0011
719 HAND DEFORMITY 14 0.0011
720 HEPATIC CIRRHOSIS 20 0.0011
721 SINUS DISORDER 21 0.0011
722 PAIN 647 0.0011
723 CELLULITIS 53 0.0011
724 HYPERHIDROSIS 135 0.0010
725 PELVIC PAIN 19 0.0010
726 THERAPY NON-RESPONDER 47 0.0010
727 MALIGNANT MELANOMA 14 0.0010
728 GASTROINTESTINAL HAEMORRHAGE 87 0.0010
729 MUCOSAL INFLAMMATION 27 0.0010
730 SYNCOPE 103 0.0010
731 IMPAIRED GASTRIC EMPTYING 14 0.0010
732 LACRIMATION INCREASED 31 0.0010
733 PANCREATITIS ACUTE 23 0.0010
734 LIVER INJURY 25 0.0010
735 WHITE BLOOD CELL COUNT DECREASED 110 0.0010
736 FAECES DISCOLOURED 22 0.0010
737 ACTIVITIES OF DAILY LIVING IMPAIRED 20 0.0010
738 PYREXIA 346 0.0010
739 INFLUENZA 111 0.0010
740 HEPATITIS C 12 0.0010
741 DECREASED APPETITE 230 0.0010
742 ABDOMINAL PAIN LOWER 25 0.0010
743 PRODUCT USE IN UNAPPROVED INDICATION 244 0.0010
744 LEUKOPENIA 49 0.0010
745 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 47 0.0010
746 ENCEPHALOPATHY 24 0.0010
747 NASOPHARYNGITIS 179 0.0010
748 HYPERTHYROIDISM 14 0.0010
749 JAUNDICE 26 0.0010
750 DRUG INEFFECTIVE 1272 0.0010
751 BACTERIAL INFECTION 18 0.0010
752 COAGULOPATHY 16 0.0010
753 LIMB INJURY 26 0.0010
754 MUSCLE TWITCHING 22 0.0010
755 UPPER LIMB FRACTURE 19 0.0010
756 MEDICATION ERROR 53 0.0010
757 INTENTIONAL OVERDOSE 61 0.0010
758 BRAIN OEDEMA 12 0.0009
759 INTENTIONAL DOSE OMISSION 27 0.0009
760 ABNORMAL DREAMS 26 0.0009
761 PRODUCT ADMINISTRATION ERROR 19 0.0009
762 TOOTHACHE 17 0.0009
763 DIZZINESS 467 0.0009
764 VOMITING 440 0.0009
765 PRODUCT DOSE OMISSION 61 0.0009
766 COORDINATION ABNORMAL 13 0.0009
767 ERUCTATION 18 0.0009
768 SKIN ULCER 24 0.0009
769 EYE PRURITUS 31 0.0009
770 RASH ERYTHEMATOUS 44 0.0009
771 HAEMORRHAGE 96 0.0009
772 PERITONITIS 19 0.0009
773 INSURANCE ISSUE 14 0.0009
774 RASH MACULAR 32 0.0009
775 TACHYCARDIA 81 0.0009
776 BRONCHOSPASM 13 0.0009
777 HYPOACUSIS 39 0.0009
778 ANGIOEDEMA 40 0.0009
779 DISCOMFORT 55 0.0009
780 MENTAL STATUS CHANGES 25 0.0009
781 CHEST DISCOMFORT 92 0.0009
782 CONSTIPATION 195 0.0009
783 PERICARDITIS 15 0.0009
784 PRODUCT SUBSTITUTION ISSUE 51 0.0009
785 PNEUMOTHORAX 14 0.0009
786 C-REACTIVE PROTEIN INCREASED 32 0.0009
787 INTENTIONAL PRODUCT USE ISSUE 77 0.0009
788 DIARRHOEA 567 0.0009
789 ACUTE HEPATIC FAILURE 12 0.0009
790 DIABETIC KETOACIDOSIS 21 0.0009
791 BLISTER 49 0.0009
792 DERMATITIS ATOPIC 46 0.0009
793 NEURALGIA 21 0.0009
794 DRUG DOSE OMISSION 142 0.0009
795 HEPATIC FUNCTION ABNORMAL 32 0.0009
796 HEAD INJURY 27 0.0009
797 MALAISE 374 0.0009
798 DRUG ERUPTION 15 0.0008
799 PALLOR 23 0.0008
800 ABDOMINAL DISTENSION 87 0.0008
801 MUSCLE SPASMS 152 0.0008
802 RIB FRACTURE 17 0.0008
803 CYSTITIS 26 0.0008
804 INCORRECT DOSE ADMINISTERED 186 0.0008
805 MUSCULOSKELETAL STIFFNESS 71 0.0008
806 NEUTROPHIL COUNT DECREASED 33 0.0008
807 PHARMACEUTICAL PRODUCT COMPLAINT 21 0.0008
808 PANCYTOPENIA 45 0.0008
809 NASAL CONGESTION 47 0.0008
810 HEART RATE INCREASED 79 0.0008
811 POLLAKIURIA 33 0.0008
812 DRUG INTERACTION 125 0.0008
813 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
814 PRESYNCOPE 19 0.0008
815 INFLUENZA LIKE ILLNESS 64 0.0008
816 SYNOVITIS 14 0.0008
817 BURNING SENSATION 54 0.0008
818 PRURITUS 293 0.0008
819 OSTEONECROSIS 25 0.0008
820 CONTUSION 73 0.0008
821 RASH PRURITIC 41 0.0008
822 PARAESTHESIA 118 0.0007
823 CARDIOVASCULAR DISORDER 19 0.0007
824 SWELLING 70 0.0007
825 DRUG EFFECT DECREASED 40 0.0007
826 FLATULENCE 42 0.0007
827 BLOOD POTASSIUM INCREASED 12 0.0007
828 THROAT IRRITATION 33 0.0007
829 LYMPHOCYTE COUNT DECREASED 13 0.0007
830 URINARY TRACT INFECTION 125 0.0007
831 INFECTION 105 0.0007
832 COVID-19 127 0.0007
833 OSTEOMYELITIS 13 0.0007
834 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 51 0.0007
835 HYPOAESTHESIA 107 0.0007
836 SOMNOLENCE 143 0.0007
837 PAIN IN EXTREMITY 209 0.0007
838 COGNITIVE DISORDER 33 0.0007
839 PSORIASIS 91 0.0007
840 LOSS OF CONSCIOUSNESS 89 0.0007
841 MEMORY IMPAIRMENT 95 0.0007
842 NEOPLASM PROGRESSION 24 0.0007
843 RESPIRATORY ARREST 19 0.0007
844 HYPERTENSION 146 0.0007
845 CLOSTRIDIUM DIFFICILE INFECTION 15 0.0007
846 RHEUMATOID ARTHRITIS 78 0.0007
847 EPILEPSY 21 0.0007
848 INCREASED APPETITE 13 0.0007
849 STOMATITIS 41 0.0007
850 TOOTH DISORDER 15 0.0007
851 ASTHMA 76 0.0007
852 NERVOUSNESS 35 0.0007
853 SNEEZING 15 0.0007
854 THROAT TIGHTNESS 18 0.0007
855 OFF LABEL USE 579 0.0007
856 THROMBOSIS 53 0.0007
857 WEIGHT INCREASED 147 0.0007
858 CATARACT 39 0.0007
859 MOVEMENT DISORDER 21 0.0007
860 HAEMOGLOBIN DECREASED 67 0.0007
861 RHINORRHOEA 42 0.0006
862 ABASIA 16 0.0006
863 DISEASE PROGRESSION 76 0.0006
864 PSORIATIC ARTHROPATHY 26 0.0006
865 HYPOGLYCAEMIA 31 0.0006
866 RASH MACULO-PAPULAR 14 0.0006
867 PRODUCTIVE COUGH 30 0.0006
868 GAIT INABILITY 21 0.0006
869 SKIN BURNING SENSATION 45 0.0006
870 FEELING HOT 38 0.0006
871 HEART RATE IRREGULAR 14 0.0006
872 CHILLS 72 0.0006
873 WOUND 17 0.0006
874 MUSCULAR WEAKNESS 69 0.0006
875 HYPOKALAEMIA 28 0.0006
876 RESPIRATORY DISORDER 18 0.0006
877 PAIN IN JAW 17 0.0006
878 SEIZURE 69 0.0006
879 WITHDRAWAL SYNDROME 25 0.0006
880 THERAPEUTIC RESPONSE DECREASED 36 0.0006
881 VERTIGO 36 0.0006
882 FLUSHING 60 0.0006
883 UNDERDOSE 43 0.0006
884 DRUG ADMINISTRATION ERROR 18 0.0006
885 STEVENS-JOHNSON SYNDROME 13 0.0006
886 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 17 0.0006
887 ASTHENIA 217 0.0006
888 RESPIRATORY TRACT INFECTION 15 0.0006
889 OEDEMA PERIPHERAL 69 0.0006
890 APHASIA 17 0.0006
891 DYSARTHRIA 21 0.0006
892 HERPES ZOSTER 32 0.0006
893 CARDIAC DISORDER 52 0.0006
894 JOINT SWELLING 67 0.0006
895 GAIT DISTURBANCE 106 0.0006
896 COUGH 155 0.0006
897 OXYGEN SATURATION DECREASED 31 0.0006
898 RESPIRATORY DISTRESS 15 0.0005
899 DEVICE BREAKAGE 22 0.0005
900 SEDATION 14 0.0005
901 HOT FLUSH 40 0.0005
902 FEBRILE NEUTROPENIA 35 0.0005
903 THROMBOCYTOPENIA 59 0.0005
904 DIABETES MELLITUS 40 0.0005
905 RED BLOOD CELL COUNT DECREASED 15 0.0005
906 DELIRIUM 18 0.0005
907 GYNAECOMASTIA 16 0.0005
908 BONE DENSITY DECREASED 16 0.0005
909 HAEMOPTYSIS 14 0.0005
910 HAEMATOMA 13 0.0005
911 DYSPNOEA 283 0.0005
912 PRODUCT DOSE OMISSION IN ERROR 14 0.0005
913 RESTLESSNESS 18 0.0005
914 ANAPHYLACTIC REACTION 27 0.0005
915 ANGINA PECTORIS 14 0.0005
916 MOBILITY DECREASED 35 0.0005
917 ARRHYTHMIA 23 0.0005
918 ASCITES 14 0.0005
919 BLOOD CREATININE INCREASED 31 0.0005
920 PRODUCT STORAGE ERROR 41 0.0005
921 OVERDOSE 101 0.0005
922 HYPERGLYCAEMIA 17 0.0005
923 BLOOD PRESSURE INCREASED 71 0.0005
924 NEUTROPENIA 61 0.0004
925 DRUG-INDUCED LIVER INJURY 14 0.0004
926 CONFUSIONAL STATE 72 0.0004
927 DYSSTASIA 13 0.0004
928 GENERAL PHYSICAL HEALTH DETERIORATION 51 0.0004
929 BLOOD PRESSURE DECREASED 29 0.0004
930 THERAPEUTIC PRODUCT EFFECT DECREASED 19 0.0004
931 RENAL FAILURE ACUTE 18 0.0004
932 NEOPLASM MALIGNANT 28 0.0004
933 DEVICE EXPULSION 27 0.0004
934 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
935 SEPTIC SHOCK 18 0.0004
936 PLEURAL EFFUSION 25 0.0004
937 DYSPHONIA 24 0.0004
938 OEDEMA 22 0.0004
939 DEVICE DISLOCATION 17 0.0004
940 ELECTROCARDIOGRAM QT PROLONGED 14 0.0004
941 TYPE 2 DIABETES MELLITUS 13 0.0004
942 TREMOR 64 0.0004
943 BLOOD GLUCOSE INCREASED 71 0.0004
944 EXPIRED PRODUCT ADMINISTERED 12 0.0004
945 SEPSIS 40 0.0004
946 HOSPITALISATION 55 0.0004
947 NEUROPATHY PERIPHERAL 34 0.0004
948 THERAPEUTIC RESPONSE UNEXPECTED 16 0.0004
949 ACCIDENTAL OVERDOSE 13 0.0004
950 RENAL FAILURE 46 0.0003
951 PNEUMONIA 112 0.0003
952 INTENTIONAL PRODUCT MISUSE 30 0.0003
953 HYPOXIA 12 0.0003
954 DISORIENTATION 13 0.0003
955 INFUSION RELATED REACTION 21 0.0003
956 FLUID RETENTION 16 0.0003
957 HYPOTENSION 63 0.0003
958 DEATH 261 0.0003
959 MALIGNANT NEOPLASM PROGRESSION 31 0.0003
960 BREAST CANCER 28 0.0003
961 EXTRA DOSE ADMINISTERED 12 0.0003
962 DYSKINESIA 12 0.0003
963 CEREBROVASCULAR ACCIDENT 50 0.0003
964 SPEECH DISORDER 15 0.0003
965 HYPONATRAEMIA 16 0.0003
966 BALANCE DISORDER 24 0.0003
967 CARDIAC FAILURE 22 0.0003
968 PLATELET COUNT DECREASED 29 0.0003
969 MULTIPLE SCLEROSIS 13 0.0003
970 LUNG DISORDER 13 0.0003
971 COMA 12 0.0003
972 INTERSTITIAL LUNG DISEASE 12 0.0002
973 BRADYCARDIA 13 0.0002
974 PERIPHERAL SWELLING 37 0.0002
975 WHEEZING 14 0.0002
976 CARDIAC ARREST 19 0.0002
977 FALL 74 0.0002
978 MYOCARDIAL INFARCTION 35 0.0002
979 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 39 0.0002
980 RESPIRATORY FAILURE 14 0.0002
981 DYSGEUSIA 14 0.0002
982 CHRONIC KIDNEY DISEASE 14 0.0002
983 ACUTE KIDNEY INJURY 28 0.0002
984 TOXICITY TO VARIOUS AGENTS 29 0.0002
985 DRUG ABUSE 13 0.0002
986 CARDIAC FAILURE CONGESTIVE 12 0.0001
987 ACCIDENTAL EXPOSURE TO PRODUCT 15 0.0001
988 INJECTION SITE PAIN 37 0.0001
989 DRUG DEPENDENCE 19 0.0001